Global Pet Deworming Drugs Market Growth 2025-2031

Publication ID:

LPI04254386

Publication Date:

April 23, 2025

Pages:

125

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pet Deworming Drugs market size is predicted to grow from US$ 366 million in 2025 to US$ 608 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.
According to the data from the company"s "Pet Products Research Center", the global pet industry will reach US$246 billion in 2022, a year-on-year increase of 11.3%. The United States has the highest pet penetration rate and the largest pet consumer market. According to the American Pet Products Association (APPA), 66% of American households own pets, and the total industry sales are about 136.8 billion US dollars, an increase of 10.8% over 2021. . According to IVH, the German pet products industry association, the number of pets in Germany will reach 33.4 million in 2022, with a total turnover of nearly 6.5 billion euros.
The 鈥淧et Deworming Drugs Industry Forecast鈥� looks at past sales and reviews total world Pet Deworming Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Deworming Drugs sales for 2025 through 2031. With Pet Deworming Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Deworming Drugs industry.
This Insight Report provides a comprehensive analysis of the global Pet Deworming Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Deworming Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pet Deworming Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Deworming Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Deworming Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Deworming Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Injecting Drugs
Oral Drugs
Others
Segmentation by Application:
Cats
Dogs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Advantage Multi
Bayer
Bimeda Animal Health
Boehringer Ingelheim
Dechra Pharmaceuticals
Droncit
Drontal Plus
Elanco
Merck
Trifexis
Vetoquinol
Zoetis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pet Deworming Drugs market?
What factors are driving Pet Deworming Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Deworming Drugs market opportunities vary by end market size?
How does Pet Deworming Drugs break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Deworming Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pet Deworming Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pet Deworming Drugs by Country/Region, 2020, 2024 & 2031
2.2 Pet Deworming Drugs Segment by Type
2.2.1 Injecting Drugs
2.2.2 Oral Drugs
2.2.3 Others
2.3 Pet Deworming Drugs Sales by Type
2.3.1 Global Pet Deworming Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Pet Deworming Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pet Deworming Drugs Sale Price by Type (2020-2025)
2.4 Pet Deworming Drugs Segment by Application
2.4.1 Cats
2.4.2 Dogs
2.4.3 Others
2.5 Pet Deworming Drugs Sales by Application
2.5.1 Global Pet Deworming Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Pet Deworming Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pet Deworming Drugs Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pet Deworming Drugs Breakdown Data by Company
3.1.1 Global Pet Deworming Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Pet Deworming Drugs Sales Market Share by Company (2020-2025)
3.2 Global Pet Deworming Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Pet Deworming Drugs Revenue by Company (2020-2025)
3.2.2 Global Pet Deworming Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Pet Deworming Drugs Sale Price by Company
3.4 Key Manufacturers Pet Deworming Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Deworming Drugs Product Location Distribution
3.4.2 Players Pet Deworming Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pet Deworming Drugs by Geographic Region
4.1 World Historic Pet Deworming Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Pet Deworming Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pet Deworming Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pet Deworming Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Pet Deworming Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pet Deworming Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pet Deworming Drugs Sales Growth
4.4 APAC Pet Deworming Drugs Sales Growth
4.5 Europe Pet Deworming Drugs Sales Growth
4.6 Middle East & Africa Pet Deworming Drugs Sales Growth
5 Americas
5.1 Americas Pet Deworming Drugs Sales by Country
5.1.1 Americas Pet Deworming Drugs Sales by Country (2020-2025)
5.1.2 Americas Pet Deworming Drugs Revenue by Country (2020-2025)
5.2 Americas Pet Deworming Drugs Sales by Type (2020-2025)
5.3 Americas Pet Deworming Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Deworming Drugs Sales by Region
6.1.1 APAC Pet Deworming Drugs Sales by Region (2020-2025)
6.1.2 APAC Pet Deworming Drugs Revenue by Region (2020-2025)
6.2 APAC Pet Deworming Drugs Sales by Type (2020-2025)
6.3 APAC Pet Deworming Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Deworming Drugs by Country
7.1.1 Europe Pet Deworming Drugs Sales by Country (2020-2025)
7.1.2 Europe Pet Deworming Drugs Revenue by Country (2020-2025)
7.2 Europe Pet Deworming Drugs Sales by Type (2020-2025)
7.3 Europe Pet Deworming Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Deworming Drugs by Country
8.1.1 Middle East & Africa Pet Deworming Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pet Deworming Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Pet Deworming Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Pet Deworming Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Deworming Drugs
10.3 Manufacturing Process Analysis of Pet Deworming Drugs
10.4 Industry Chain Structure of Pet Deworming Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Deworming Drugs Distributors
11.3 Pet Deworming Drugs Customer
12 World Forecast Review for Pet Deworming Drugs by Geographic Region
12.1 Global Pet Deworming Drugs Market Size Forecast by Region
12.1.1 Global Pet Deworming Drugs Forecast by Region (2026-2031)
12.1.2 Global Pet Deworming Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pet Deworming Drugs Forecast by Type (2026-2031)
12.7 Global Pet Deworming Drugs Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Advantage Multi
13.1.1 Advantage Multi Company Information
13.1.2 Advantage Multi Pet Deworming Drugs Product Portfolios and Specifications
13.1.3 Advantage Multi Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Advantage Multi Main Business Overview
13.1.5 Advantage Multi Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Pet Deworming Drugs Product Portfolios and Specifications
13.2.3 Bayer Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Bimeda Animal Health
13.3.1 Bimeda Animal Health Company Information
13.3.2 Bimeda Animal Health Pet Deworming Drugs Product Portfolios and Specifications
13.3.3 Bimeda Animal Health Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bimeda Animal Health Main Business Overview
13.3.5 Bimeda Animal Health Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Pet Deworming Drugs Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Dechra Pharmaceuticals
13.5.1 Dechra Pharmaceuticals Company Information
13.5.2 Dechra Pharmaceuticals Pet Deworming Drugs Product Portfolios and Specifications
13.5.3 Dechra Pharmaceuticals Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Dechra Pharmaceuticals Main Business Overview
13.5.5 Dechra Pharmaceuticals Latest Developments
13.6 Droncit
13.6.1 Droncit Company Information
13.6.2 Droncit Pet Deworming Drugs Product Portfolios and Specifications
13.6.3 Droncit Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Droncit Main Business Overview
13.6.5 Droncit Latest Developments
13.7 Drontal Plus
13.7.1 Drontal Plus Company Information
13.7.2 Drontal Plus Pet Deworming Drugs Product Portfolios and Specifications
13.7.3 Drontal Plus Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Drontal Plus Main Business Overview
13.7.5 Drontal Plus Latest Developments
13.8 Elanco
13.8.1 Elanco Company Information
13.8.2 Elanco Pet Deworming Drugs Product Portfolios and Specifications
13.8.3 Elanco Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Elanco Main Business Overview
13.8.5 Elanco Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Pet Deworming Drugs Product Portfolios and Specifications
13.9.3 Merck Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Trifexis
13.10.1 Trifexis Company Information
13.10.2 Trifexis Pet Deworming Drugs Product Portfolios and Specifications
13.10.3 Trifexis Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Trifexis Main Business Overview
13.10.5 Trifexis Latest Developments
13.11 Vetoquinol
13.11.1 Vetoquinol Company Information
13.11.2 Vetoquinol Pet Deworming Drugs Product Portfolios and Specifications
13.11.3 Vetoquinol Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Vetoquinol Main Business Overview
13.11.5 Vetoquinol Latest Developments
13.12 Zoetis
13.12.1 Zoetis Company Information
13.12.2 Zoetis Pet Deworming Drugs Product Portfolios and Specifications
13.12.3 Zoetis Pet Deworming Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Zoetis Main Business Overview
13.12.5 Zoetis Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂